John A. Blessing

Prognostic factors in early‐stage uterine sarcoma: A gynecologic oncology group study

Francis J. Major, John A. Blessing, Steven G. Silverberg et al. · Cancer · 1993 · 665 citations · Full text

Medicine, Gynecology, Oncology +14

Phase III Study of Cisplatin With or Without Paclitaxel in Stage IVB, Recurrent, or Persistent Squamous Cell Carcinoma of the Cervix: A Gynecologic Oncology Group Study

David H. Moore, John A. Blessing, Richard P. McQuellon et al. · Journal of Clinical Oncology · 2004 · 641 citations · Full text

Medicine, Oncology, Radiation Oncology +13

Randomized trial of three cisplatin dose schedules in squamous-cell carcinoma of the cervix: a Gynecologic Oncology Group study.

Philip Bonomi, John A. Blessing, Frederick B. Stehman et al. · Journal of Clinical Oncology · 1985 · 406 citations

Medicine, Oncology, Pharmacotherapy +15

Prolonged oral etoposide as second-line therapy for platinum-resistant and platinum-sensitive ovarian carcinoma: a Gynecologic Oncology Group study.

Peter G. Rose, John A. Blessing, Andrew R. Mayer et al. · Journal of Clinical Oncology · 1998 · 403 citations

Medicine, Oncology, Pharmacology +17

A randomized clinical trial of adjuvant adriamycin in uterine sarcomas: a Gynecologic Oncology Group Study.

G A Omura, John A. Blessing, Francis J. Major et al. · Journal of Clinical Oncology · 1985 · 399 citations

Medicine, Gynecology, Oncology +15